The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Self-citationGut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952
The gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Armstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Self-citationInker, L. A., Astor, B. C., Fox, C. H., Isakova, T., Lash, J. P., Peralta, C. A., Kurella Tamura, M., & Feldman, H. I. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.416 · Cited by 1,779
Hernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · Hepatology · doi:10.1002/hep.24452 · Cited by 1,585
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483
The microbiology of butyrate formation in the human colon
Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S., & Flint, H. J. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11467.x · Cited by 1,320
Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317
Tang, W. H. W., Wang, Z., Kennedy, D. J., Wu, Y., Buffa, J. A., Agatisa-Boyle, B., Li, X. S., Levison, B. S., & Hazen, S. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.305360 · Cited by 1,223
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136
Charlton, M. R., Burns, J. M., Pedersen, R. A., Watt, K. D., Heimbach, J. K., & Dierkhising, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,106
Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Cusi, K., Orsak, B., Bril, F., Lomonaco, R., Hecht, J., Ortiz-Lopez, C., Tio, F., Hardies, J., Darland, C., Musi, N., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1774 · Cited by 1,024
Decoding cell death signals in liver inflammation
Brenner, C., Galluzzi, L., Kepp, O., & Kroemer, G. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.033 · Cited by 1,022
Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut
Barcenilla, A., Pryde, S. E., Martin, J. C., Duncan, S. H., Stewart, C. S., Henderson, C., & Flint, H. J. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.4.1654-1661.2000 · Cited by 995
Psichas, A., Sleeth, M. L., Murphy, K. G., Brooks, L., Bewick, G. A., Hanyaloglu, A. C., Ghatei, M. A., Bloom, S. R., & Frost, G. (2015) · International Journal of Obesity · doi:10.1038/ijo.2014.153 · Cited by 886
Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837
Schneeberger, M., Everard, A., Gómez-Valadés, A. G., Matamoros, S., Ramírez, S., Delzenne, N. M., Gomis, R., Claret, M., & Cani, P. D. (2015) · Scientific Reports · doi:10.1038/srep16643 · Cited by 798
Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001680 · Cited by 720
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
Softic, S., Cohen, D. E., & Kahn, C. R. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4054-0 · Cited by 709
Athyros, V. G., Tziomalos, K., Gossios, T. D., Griva, T., Anagnostis, P., Kargiotis, K., Pagourelias, E. D., Theocharidou, E., Karagiannis, A., & Mikhailidis, D. P. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61272-x · Cited by 685
Wong, J., Piceno, Y. M., DeSantis, T. Z., Pahl, M., Andersen, G. L., & Vaziri, N. D. (2014) · American Journal of Nephrology · doi:10.1159/000360010 · Cited by 638
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
DeFronzo, R. A., Norton, L., & Abdul-Ghani, M. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.170 · Cited by 553
Causes and Metabolic Consequences of Fatty Liver
Stefan, N., Kantartzis, K., & Häring, H.-U. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 532
p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease
Wu, I.-W., Hsu, K.-H., Lee, C.-C., Sun, C.-Y., Hsu, H.-J., Tsai, C.-J., Tzen, C.-Y., Wang, Y.-C., Lin, C.-Y., & Wu, M.-S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq580 · Cited by 510
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 496
Self-citationVallon, V., Gerasimova, M., Rose, M. A., Masuda, T., Satriano, J., Mayoux, E., Koepsell, H., Thomson, S. C., & Rieg, T. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00520.2013 · Cited by 483
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.005 · Cited by 452
Insulin resistance in chronic kidney disease: a systematic review
Spoto, B., Pisano, A., & Zoccali, C. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00340.2016 · Cited by 450
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez-Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 444
Self-citationGomez, I. G., MacKenna, D. A., Johnson, B. G., Kaimal, V., Roach, A. M., Ren, S., Nakagawa, N., Xin, C., Newitt, R., Pandya, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75852 · Cited by 413
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Rotman, Y., & Sanyal, A. J. (2017) · Gut · doi:10.1136/gutjnl-2016-312431 · Cited by 410
Bugianesi, E., Pagotto, U., Manini, R., Vanni, E., Gastaldelli, A., de Iasio, R., Gentilcore, E., Natale, S., Cassader, M., Rizzetto, M., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2240 · Cited by 408
Statin use and non-alcoholic steatohepatitis in at risk individuals
Dongiovanni, P., Petta, S., Mannisto, V., Mancina, R. M., Pipitone, R., Karja, V., Maggioni, M., Kakela, P., Wiklund, O., Mozzi, E., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.006 · Cited by 390
Targher, G., Bertolini, L., Rodella, S., Zoppini, G., Lippi, G., Day, C., & Muggeo, M. (2008) · Diabetologia · doi:10.1007/s00125-007-0897-4 · Cited by 383
Self-citationMolecular pathways in non-alcoholic fatty liver disease
Auguet, T., Berlanga, A., Guiu-Jurado, E., & Porras, J. A. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s62831 · Cited by 379
n -3 Fatty acids, inflammation and immunity: new mechanisms to explain old actions
Calder, P. C. (2013) · Proceedings of the Nutrition Society · doi:10.1017/s0029665113001031 · Cited by 364
Athyros, V. G., Mikhailidis, D. P., Papageorgiou, A. A., Symeonidis, A. N., Pehlivanidis, A. N., Bouloukos, V. I., & Elisaf, M. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.012989 · Cited by 353
MicroRNAs in kidney physiology and disease
Trionfini, P., Benigni, A., & Remuzzi, G. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.202 · Cited by 353
Ix, J. H., & Sharma, K. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009080820 · Cited by 348
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Palmer, S. C., Navaneethan, S. D., Craig, J. C., Johnson, D. W., Perkovic, V., Hegbrant, J., & Strippoli, G. F. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007784.pub2 · Cited by 331
Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease
Scorletti, E., & Byrne, C. D. (2013) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161230 · Cited by 326
Self-citationScorletti, E., Bhatia, L., McCormick, K. G., Clough, G. F., Nash, K., Hodson, L., Moyses, H. E., Calder, P. C., Byrne, C. D., Sheron, N., et al. (2014) · Hepatology · doi:10.1002/hep.27289 · Cited by 310
Self-citationSanyal, A. J., Abdelmalek, M. F., Suzuki, A., Cummings, O. W., & Chojkier, M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.046 · Cited by 309
Shepherd, J., Kastelein, J. J. P., Bittner, V., Deedwania, P., Breazna, A., Dobson, S., Wilson, D. J., Zuckerman, A., & Wenger, N. K. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04371206 · Cited by 275
Noninvasive evaluation of NAFLD
Castera, L., Vilgrain, V., & Angulo, P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.175 · Cited by 273
Baeck, C., Wei, X., Bartneck, M., Fech, V., Heymann, F., Gassler, N., Hittatiya, K., Eulberg, D., Luedde, T., Trautwein, C., et al. (2014) · Hepatology · doi:10.1002/hep.26783 · Cited by 270
p-Cresyl Sulfate Promotes Insulin Resistance Associated with CKD
Koppe, L., Pillon, N. J., Vella, R. E., Croze, M. L., Pelletier, C. C., Chambert, S., Massy, Z., Glorieux, G., Vanholder, R., Dugenet, Y., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012050503 · Cited by 270
Metabolic disturbances in non-alcoholic fatty liver disease
Byrne, C. D., Olufadi, R., Bruce, K. D., Cagampang, F. R., & Ahmed, M. H. (2009) · Clinical Science · doi:10.1042/cs20080253 · Cited by 258
Self-citationGut microbiome in chronic kidney disease: challenges and opportunities
Nallu, A., Sharma, S., Ramezani, A., Muralidharan, J., & Raj, D. (2017) · Translational Research · doi:10.1016/j.trsl.2016.04.007 · Cited by 255
Simon, M.-C., Strassburger, K., Nowotny, B., Kolb, H., Nowotny, P., Burkart, V., Zivehe, F., Hwang, J.-H., Stehle, P., Pacini, G., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2690 · Cited by 253
Non-alcoholic fatty liver and the gut microbiota
Bashiardes, S., Shapiro, H., Rozin, S., Shibolet, O., & Elinav, E. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.003 · Cited by 241
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations
Zampino, R., Marrone, A., Restivo, L., Guerrera, B., Sellitto, A., Rinaldi, L., Romano, C., & Adinolfi, L. E. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i10.528 · Cited by 234
Targher, G., Bertolini, L., Rodella, S., Lippi, G., Zoppini, G., & Chonchol, M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05050610 · Cited by 233
Self-citationIncreased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M., Bertolini, L., Rodella, S., Zenari, L., Lippi, G., Franchini, M., Zoppini, G., & Muggeo, M. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101155 · Cited by 232
Self-citationBarchetta, I., Carotti, S., Labbadia, G., Gentilucci, U. V., Muda, A. O., Angelico, F., Silecchia, G., Leonetti, F., Fraioli, A., Picardi, A., et al. (2012) · Hepatology · doi:10.1002/hep.25930 · Cited by 229
Skov, J., Dejgaard, A., Frøkiær, J., Holst, J. J., Jonassen, T., Rittig, S., & Christiansen, J. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3855 · Cited by 228
Petit, J.-M., Cercueil, J.-P., Loffroy, R., Denimal, D., Bouillet, B., Fourmont, C., Chevallier, O., Duvillard, L., & Vergès, B. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2775 · Cited by 227
Tonelli, M., Wanner, C., & for the Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2453 · Cited by 226
Argo, C. K., Patrie, J. T., Lackner, C., Henry, T. D., de Lange, E. E., Weltman, A. L., Shah, N. L., Al-Osaimi, A. M., Pramoonjago, P., Jayakumar, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.036 · Cited by 224
Links Between Ectopic Fat and Vascular Disease in Humans
Lim, S., & Meigs, J. B. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303035 · Cited by 217
Mechanisms Linking the Gut Microbiome and Glucose Metabolism
Utzschneider, K. M., Kratz, M., Damman, C. J., & Hullarg, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4251 · Cited by 214
CKD and Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M. B., & Byrne, C. D. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.05.019 · Cited by 213
Self-citationSystematic review: microbial dysbiosis and nonalcoholic fatty liver disease
Wieland, A., Frank, D. N., Harnke, B., & Bambha, K. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13376 · Cited by 207
Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies
Kufareva, I., Salanga, C. L., & Handel, T. M. (2015) · Immunology & Cell Biology · doi:10.1038/icb.2015.15 · Cited by 200
Yokono, M., Takasu, T., Hayashizaki, Y., Mitsuoka, K., Kihara, R., Muramatsu, Y., Miyoshi, S., Tahara, A., Kurosaki, E., Li, Q., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.040 · Cited by 195
Chronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight Junction
Vaziri, N. D., Yuan, J., Nazertehrani, S., Ni, Z., & Liu, S. (2013) · American Journal of Nephrology · doi:10.1159/000353764 · Cited by 195
Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease
Kendrick, J., & Chonchol, M. B. (2008) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0954 · Cited by 182
Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease
Souza-Mello, V. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i8.1012 · Cited by 182
Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective
Han, J.-L., & Lin, H.-L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17737 · Cited by 179
Georgescu, E. F., Ionescu, R., Niculescu, M., Mogoanta, L., & Vancica, L. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.942 · Cited by 177
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms
Adinolfi, L. E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i13.3410 · Cited by 174
Xu, Y., Li, F., Zalzala, M., Xu, J., Gonzalez, F. J., Adorini, L., Lee, Y., Yin, L., & Zhang, Y. (2016) · Hepatology · doi:10.1002/hep.28712 · Cited by 172
Targher, G., Bertolini, L., Rodella, S., Zoppini, G., Scala, L., Zenari, L., & Falezza, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02527.x · Cited by 172
Self-citationBergeron, N., Phan, B. A. P., Ding, Y., Fong, A., & Krauss, R. M. (2015) · Circulation · doi:10.1161/circulationaha.115.016080 · Cited by 171
The Renin Angiotensin Aldosterone System in Obesity and Hypertension
Cabandugama, P. K., Gardner, M. J., & Sowers, J. R. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.009 · Cited by 168
Chang, Y., Ryu, S., Sung, E., Woo, H.-Y., Oh, E., Cha, K., Jung, E., & Kim, W. S. (2008) · Metabolism · doi:10.1016/j.metabol.2007.11.022 · Cited by 164
Singh, S., Khera, R., Allen, A. M., Murad, M. H., & Loomba, R. (2015) · Hepatology · doi:10.1002/hep.27999 · Cited by 163
Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging
Vlassara, H., Torreggiani, M., Post, J. B., Zheng, F., Uribarri, J., & Striker, G. E. (2009) · Kidney International · doi:10.1038/ki.2009.401 · Cited by 163
Targher, G., Mantovani, A., Pichiri, I., Mingolla, L., Cavalieri, V., Mantovani, W., Pancheri, S., Trombetta, M., Zoppini, G., Chonchol, M., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2704 · Cited by 162
Self-citationThe Gordian Knot of dysbiosis, obesity and NAFLD
Mehal, W. Z. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.146 · Cited by 160
Emerging risk factors and markers of chronic kidney disease progression
Kronenberg, F. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.173 · Cited by 160
Nonalcoholic steatohepatitis and increased risk of chronic kidney disease
Yasui, K., Sumida, Y., Mori, Y., Mitsuyoshi, H., Minami, M., Itoh, Y., Kanemasa, K., Matsubara, H., Okanoue, T., & Yoshikawa, T. (2011) · Metabolism · doi:10.1016/j.metabol.2010.07.022 · Cited by 159
Tikkanen, M. J., Fayyad, R. S., Færgeman, O., OLSSON, A. G., Wun, C., Laskey, R. E., Kastelein, J. J. P., Holme, I., & Pedersen, T. R. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.024 · Cited by 159
Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease
Choi, B.-H., Kang, K.-S., & Kwak, M.-K. (2014) · Molecules · doi:10.3390/molecules190812727 · Cited by 159
Beilfuss, A., Sowa, J.-P., Sydor, S., Beste, M., Bechmann, L. P., Schlattjan, M., Syn, W.-K., Wedemeyer, I., Mathé, Z., Jochum, C., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307024 · Cited by 159
Targher, G., Bertolini, L., Chonchol, M., Rodella, S., Zoppini, G., Lippi, G., Zenari, L., & Bonora, E. (2010) · Diabetologia · doi:10.1007/s00125-010-1720-1 · Cited by 158
Self-citationSharma, M., Mitnala, S., Vishnubhotla, R., Mukherjee, R., Reddy, D. N., & Rao, P. N. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2015.02.002 · Cited by 155
Antioxidants for chronic kidney disease
Jun, M., Venkataraman, V., Razavian, M., Cooper, B. A., Zoungas, S., Ninomiya, T., Webster, A. C., & Perkovic, V. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008176.pub2 · Cited by 153
Iacobini, C., Menini, S., Ricci, P. C., Fantauzzi, C. B., Scipioni, A., Salvi, L., Cordone, S., Delucchi, F., Sérino, M., Federici, M., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.020 · Cited by 152
(2015) · PubMed · Cited by 152
Gut microbiome and nonalcoholic fatty liver diseases
Zhu, L., Baker, R. D., & Baker, S. S. (2014) · Pediatric Research · doi:10.1038/pr.2014.157 · Cited by 148
Pawlak, M., Baugé, E., Bourguet, W., De Bosscher, K., Lalloyer, F., Tailleux, A., Lebherz, C., Lefebvre, P., & Staels, B. (2014) · Hepatology · doi:10.1002/hep.27297 · Cited by 141
PROGRESS IN UREMIC TOXIN RESEARCH: The Role of Oxidative Stress in Chronic Kidney Disease
Massy, Z. A., Stenvinkel, P., & Drüeke, T. B. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00590.x · Cited by 137
McCullough, K. P., Sharma, P., Ali, T., Khan, I. H., Smith, W. C., MacLeod, A. M., & Black, C. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr547 · Cited by 137
Emerging Liver–Kidney Interactions in Nonalcoholic Fatty Liver Disease
Musso, G., Cassader, M., Cohney, S. J., Pinach, S., Saba, F., & Gambino, R. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.08.005 · Cited by 136
Galectin-3: an emerging all-out player in metabolic disorders and their complications
Pugliese, G., Iacobini, C., Pesce, C. M., & Menini, S. (2014) · Glycobiology · doi:10.1093/glycob/cwu111 · Cited by 131
Fabrizi, F., Verdesca, S., Messa, P., & Martin, P. B. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3801-y · Cited by 131
Willy, J. A., Young-Baird, S. K., Stevens, J. L., Masuoka, H. C., & Wek, R. C. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-01-0036 · Cited by 127
The Role of the Gut Microbiome on Chronic Kidney Disease
Sampaio‐Maia, B., Simões‐Silva, L., Pestana, M., Araújo, R., & Soares‐Silva, I. (2016) · Advances in applied microbiology · doi:10.1016/bs.aambs.2016.06.002 · Cited by 123
Dattaroy, D., Pourhoseini, S., Das, S., Alhasson, F. A., Seth, R. K., Nagarkatti, M., Michelotti, G. A., Diehl, A. M., & Chatterjee, S. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00346.2014 · Cited by 119
Scorletti, E., West, A. L., Bhatia, L. S., Hoile, S. P., McCormick, K. G., Burdge, G. C., Lillycrop, K. A., Clough, G. F., Calder, P. C., & Byrne, C. D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.036 · Cited by 116
Self-citationGeorgescu, E. F., & Georgescu, M. (2007) · PubMed · Cited by 114
Renin‐angiotensin system and fibrosis in non‐alcoholic fatty liver disease
Goh, G. B., Pagadala, M. R., Dasarathy, J., Ünalp–Arida, A., Sargent, R., Hawkins, C., Sourianarayanane, A., Khiyami, A., Yerian, L. M., Pai, R. K., et al. (2014) · Liver International · doi:10.1111/liv.12611 · Cited by 114
Tsaousidou, E., Paeger, L., Belgardt, B., Pál, M., Wunderlich, C. M., Brönneke, H. S., Collienne, U., Hampel, B., Wunderlich, F. T., Schmidt‐Supprian, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.045 · Cited by 112
Pacifico, L., Bonci, E., Martino, M. D., Versacci, P., Andreoli, G., Silvestri, L. M., & Chiesa, C. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.04.003 · Cited by 111
Ectopic fat, insulin resistance and non-alcoholic fatty liver disease
Byrne, C. D. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113001249 · Cited by 110
Self-citationNymark, M., Pussinen, P. J., Tuomainen, A. M., Forsblom, C. M., Groop, P., Lehto, M. J., & on behalf of the FinnDiane Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0467 · Cited by 109
Yilmaz, Y. N., Alahdab, Y. Ö., Yönal, O., Kurt, R., Kedrah, A. E., Çelikel, Ç., Ozdogan, O. C., Duman, D., İmeryüz, N., Avşar, E., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2009.12.012 · Cited by 102
Singal, A. K., Hasanin, M., Kaif, M., Wiesner, R. H., & Kuo, Y. (2015) · Transplantation · doi:10.1097/tp.0000000000000945 · Cited by 99
Xu, P., Zhang, Y., Liu, Y., Yuan, Q., Song, L., Liu, M., Liu, Z., Yang, Y., Li, J., Li, D., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.11.012 · Cited by 97
Adiponectin: Key Player in the Adipose Tissue-Liver Crosstalk
Moschen, A. R., Wieser, V. E., & Tilg, H. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803833254 · Cited by 95
Wang, X. X., Jiang, T., Shen, Y., Santamaria, H., Solis, N., ARBEENY, C. M., & Levi, M. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00338.2010 · Cited by 90
Sirota, J. C., McFann, K., Targher, G., Chonchol, M., & Jalal, D. I. (2012) · American Journal of Nephrology · doi:10.1159/000343885 · Cited by 87
Self-citationPerspectives on Treatment for Nonalcoholic Steatohepatitis
Lassailly, G., Caiazzo, R. J., Pattou, F. N., & Mathurin, P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.004 · Cited by 87
Leti, F., Malenica, I., Doshi, M., Courtright-Lim, A., Keuren‐Jensen, K. R. V., Legendre, C., Still, C. D., Gerhard, G. S., & DiStefano, J. K. (2015) · Translational research · doi:10.1016/j.trsl.2015.04.014 · Cited by 82
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
Nakano, S., Katsuno, K., Isaji, M., Nagasawa, T., Buehrer, B. M., Walker, S., Wilkison, W. O., & Cheatham, B. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2015.02.005 · Cited by 82
Pelusi, S., Petta, S., Rosso, C., Borroni, V. N., Fracanzani, A. L., Dongiovanni, P., Craxì, A., Bugianesi, E., Fargion, S. R., & Valenti, L. V. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163069 · Cited by 82
Nonalcoholic fatty liver disease and statins
Τζιόμαλος, Κ., Athyros, V. G., Paschos, P., & Karagiannis, A. I. (2015) · Metabolism · doi:10.1016/j.metabol.2015.07.003 · Cited by 81
Zhang, H., Zhang, X., Hu, C., & Lu, W. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000337929 · Cited by 80
Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?
Alkhouri, N., & Feldstein, A. E. (2016) · Metabolism · doi:10.1016/j.metabol.2016.01.013 · Cited by 77
Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments
Scorletti, E., Calder, P. C., & Byrne, C. D. (2011) · Endocrine · doi:10.1007/s12020-011-9530-x · Cited by 75
Self-citationPlasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells
Wang, Y.-N., van der Tuin, S. V. D., Tjeerdema, N., van Dam, A. V., Rensen, S., Hendrikx, T., Berbée, J., Atanasovska, B., Fu, J.-Y., Hoekstra, M., et al. (2015) · Hepatology · doi:10.1002/hep.27985 · Cited by 75
Jia, G., Di, F., Qipeng, W., Shao, J., Gao, L., Wang, L., Li, Q., & Li, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142808 · Cited by 75
DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity
Xie, L., Wang, P., Zhang, P., Zhang, X., Zhao, G., Wang, A., Guo, J., Zhu, X., Zhang, Q., & Li, H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.008 · Cited by 72
Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease
Machado, M. V., Gonçalves, S., Carepa, F., Coutinho, J., Costa, A., & Cortez‐Pinto, H. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02623.x · Cited by 71
Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders
Zhang, J., & Li, Y. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00168 · Cited by 69
Iannelli, F., Collino, A., Sinha, S., Radaelli, E., Nicoli, P., D’Antiga, L., Sonzogni, A., Faivre, J., Buendia, M. A., Sturm, E., et al. (2014) · Nature Communications · doi:10.1038/ncomms4850 · Cited by 68
Gómez, E. V., Bertot, L. C., Friedman, S. L., Gra‐Oramas, B., Gonzalez‐Fabian, L., Villa-Jiménez, O. M., del Vallín, S. L., Diago, M., Adams, L. A., Romero‐Gómez, M., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13860 · Cited by 67
Imamura, S., Hirai, K., & Hirai, A. (2013) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.231.57 · Cited by 64
The Impact of Nonalcoholic Fatty Liver Disease on Renal Function in Children with Overweight/Obesity
Pacifico, L., Bonci, E., Andreoli, G. M., Martino, M. D., Gallozzi, A., Luca, E. D., & Chiesa, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081218 · Cited by 59
Byrne, C. D., & Targher, G. (2013) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0033-1334866 · Cited by 58
Self-citationPark, C. W., Tsai, N., & Wong, L. L. (2011) · Clinical Transplantation · doi:10.1111/j.1399-0012.2011.01497.x · Cited by 57
Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients
Cheng, A. Y. S., Kong, A. P. S., Wong, V. W., So, W., Chan, H. L., Ho, C. S., Lam, C. W. K., Tam, J. S. L., Chow, C. C., Cockram, C. S., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0294-4 · Cited by 57
Xu, H., Hsu, Y., Chang, C., Wei, K., & Lin, C. (2015) · Hepatology International · doi:10.1007/s12072-015-9690-5 · Cited by 53
Micro RNAs in the development of non-alcoholic fatty liver disease
Gerhard, G. S. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v7.i2.226 · Cited by 52
Shedding of Syndecan–1 From Human Hepatocytes Alters Very Low Density Lipoprotein Clearance
Deng, Y., Foley, E. M., Gonzales, J. C., Gordts, P. L. S. M., Li, Y., & Esko, J. D. (2011) · Hepatology · doi:10.1002/hep.24626 · Cited by 48
Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD
Nobili, V., Alisi, A., Musso, G., Scorletti, E., Calder, P. C., & Byrne, C. D. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1092106 · Cited by 47
Self-citationMedical and Surgical Treatment Options for Nonalcoholic Steatohepatitis
Corey, K. E., & Rinella, M. E. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4083-8 · Cited by 41
Orlić, L., Mikolašević, I., Lukenda, V., Anić, K., Jelić, I., & Rački, S. (2014) · Wiener klinische Wochenschrift · doi:10.1007/s00508-014-0661-y · Cited by 40
Scorletti, E., & Byrne, C. D. (2016) · Digestive Diseases · doi:10.1159/000447276 · Cited by 40
Self-citationRole of Renin-Angiotensin-Aldosterone System in Metabolic Syndrome and Obesity-related Hypertension
Kamide, K. (2014) · Current Hypertension Reviews · doi:10.2174/1573402110666140812122349 · Cited by 37
Dong, Y., Gao, G., Fan, H., Li, S., Li, X., & Liu, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124778 · Cited by 35
Pan, L., Zhang, H., Huang, Z., Sun, Q., Chen, Z., Li, Z., Yang, S., Li, X.-Y., & Li, X. (2015) · Metabolism · doi:10.1016/j.metabol.2015.06.003 · Cited by 34
Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older
Ahn, A.-L., Choi, J., Kim, M. K., Kim, S.-A., Oh, E.-J., Kweon, H.-J., & Cho, D.-Y. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.3.199 · Cited by 34
Relationship between Obesity, Gut Microbiome and Hepatocellular Carcinoma Development
Hara, E. (2015) · Digestive Diseases · doi:10.1159/000371679 · Cited by 31
Nonalcoholic fatty liver associated with impairment of kidney function in nondiabetes population.
Li, G., Shi, W., Hu, H. Z., Chen, Y., Liu, L., & Yin, D. (2012) · Biochemia Medica · doi:10.11613/bm.2012.010 · Cited by 31
Micro RNAs in the development of non-alcoholic fatty liverdisease
Glenn, Gerhard, Johanna, & DiStefano (2015) · World Journal of Hepatology · Cited by 28
Miyamoto, S., & Sharma, K. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft261 · Cited by 24
Targeting chemokines in proteinuria-induced renal disease
Moreno, J. A., Moreno, S., Rubio‐Navarro, A., Sastre, C., Blanco‐Colio, L. M., Gómez‐Guerrero, C., Ortíz, A., & Egido, J. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.703657 · Cited by 23
Hepatic Syndecan-1 Changes Associate With Dyslipidemia After Renal Transplantation
Adepu, S., Katta, K., Tietge, U. J. F., Kwakernaak, A. J., Dam, W., van Goor, H., Dullaart, R. P. F., Navis, G. J., Bakker, S. J. L., & van den Born, J. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12842 · Cited by 17
Cited by
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
Neeland, I. J., Ross, R., Després, J.-P., Matsuzawa, Y., Yamashita, S., Shai, I., Seidell, J., Magni, P., Santos, R. D., Arsenault, B., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30084-1 · Cited by 1,603
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Cotter, T. G., & Rinella, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.052 · Cited by 1,198
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Mantovani, A., Scorletti, E., Mosca, A., Alisi, A., Byrne, C. D., & Targher, G. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154170 · Cited by 553
Self-citationNAFLD as a driver of chronic kidney disease
Byrne, C. D., & Targher, G. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.013 · Cited by 449
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
Targher, G., Lonardo, A., & Byrne, C. D. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.173 · Cited by 397
Self-citation
Metadata
- Authors
- Targher, G., & Byrne, C. D.
- Venue
- Nature Reviews Nephrology
- Published
- 2017-02-20
- Volume
- 13
- Issue
- 5
- Pages
- 297-310
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W2591123944
- Cited by
- 309
- References
- 167
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.